Agilent Technologies Inc (A)
138.75
+1.71
(+1.25%)
USD |
NYSE |
May 01, 16:00
138.75
0.00 (0.00%)
After-Hours: 18:00
Agilent Technologies Cash and Short Term Investments (Quarterly): 1.748B for Jan. 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.748B |
| October 31, 2023 | 1.59B |
| July 31, 2023 | 1.329B |
| April 30, 2023 | 1.175B |
| January 31, 2023 | 1.25B |
| October 31, 2022 | 1.053B |
| July 31, 2022 | 1.077B |
| April 30, 2022 | 1.207B |
| January 31, 2022 | 1.158B |
| October 31, 2021 | 1.575B |
| July 31, 2021 | 1.428B |
| April 30, 2021 | 1.38B |
| January 31, 2021 | 1.329B |
| October 31, 2020 | 1.441B |
| July 31, 2020 | 1.358B |
| April 30, 2020 | 1.324B |
| January 31, 2020 | 1.226B |
| October 31, 2019 | 1.382B |
| July 31, 2019 | 1.765B |
| April 30, 2019 | 2.155B |
| January 31, 2019 | 2.057B |
| October 31, 2018 | 2.247B |
| July 31, 2018 | 2.131B |
| April 30, 2018 | 3.011B |
| January 31, 2018 | 2.887B |
| Date | Value |
|---|---|
| October 31, 2017 | 2.678B |
| July 31, 2017 | 2.563B |
| April 30, 2017 | 2.389B |
| January 31, 2017 | 2.241B |
| October 31, 2016 | 2.289B |
| July 31, 2016 | 2.199B |
| April 30, 2016 | 2.139B |
| January 31, 2016 | 1.931B |
| October 31, 2015 | 2.003B |
| July 31, 2015 | 2.075B |
| April 30, 2015 | 2.197B |
| January 31, 2015 | 2.118B |
| October 31, 2014 | 2.218B |
| July 31, 2014 | 2.391B |
| April 30, 2014 | 2.95B |
| January 31, 2014 | 2.742B |
| October 31, 2013 | 2.675B |
| July 31, 2013 | 2.33B |
| April 30, 2013 | 2.519B |
| January 31, 2013 | 2.45B |
| October 31, 2012 | 2.351B |
| July 31, 2012 | 1.923B |
| April 30, 2012 | 3.896B |
| January 31, 2012 | 3.662B |
| October 31, 2011 | 3.527B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.053B
Minimum
Oct 2022
1.765B
Maximum
Jul 2019
1.358B
Average
1.329B
Median
Jan 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 1.607B |
| Revvity Inc | 1.695B |
| Bruker Corp | 488.30M |
| Azenta Inc | 984.14M |
| Harvard Bioscience Inc | 4.283M |